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in the year 2000, and this was projected to increase to 366 million by 2030.2 In 2005, an 



















ated	with	 obesity,	 hypertension	 and	 elevated	 cholesterol	 (combined	hyperlipidemia),	









depends	on	 the	presence	of	 cardiovascular	disease.	Coronary	artery	disease	 (CAD)	 is	


























rate is increased either by exercise or pharmacologically with adenosine, dobutamine or 









3-dimensional dataset. This dataset may then be manipulated to show thin slices along 







is made by comparing stress images to a set of images obtained at rest. Homogeneous 











Multislice computed tomography coronary angiography and calcium scoring
Multislice	computed	tomography	(MSCT)	coronary	angiography	is	a	noninvasive	imag-
ing	technique	which	can	visualize	the	coronary	arteries	and	detect	significant	stenoses.	





















































in two dimensions. The frame-to-frame changes of the speckles are used to derive mo-






frame in each apical view, the automated algorithm traces three concentric lines on the 
endocardial	border,	the	mid-myocardial	layer	and	epicardial	border,	including	the	entire	
myocardial wall. The tracking algorithm follows the endocardium from this single frame 
throughout the cardiac cycle, and allows for a further manual adjustment of the region 





eye” plot, with the average value of peak systolic longitudinal strain for each view and 
the	averaged	global	 longitudinal	peak	systolic	strain	for	the	complete	left	ventricle.	 In	





















in a database. The extensive database formed the basis for the studies presented in this 
thesis.	At	the	time	of	writing	this	thesis,	patients	are	still	followed-up.						





CAC	 scoring	 as	 two	 complementary	 approaches	 for	 screening	 asymptomatic	 patients	
with	diabetes.	 In	addition,	on	the	basis	of	the	available	evidence	in	the	literature,	we	
proposed	a	potential	algorithm	for	this	purpose.









calcium scoring and noninvasive angiography was explored.











In chapter 8 we describe the prevalence of cardiac autonomic neuropathy in a cohort 
of	truly	asymptomatic	patients	with	DM	type	2	using	heart	rate	variability	and	123I-me-
taiodobenzylguanidine	myocardial	scintigraphy.
Chapter 9 contains the summary and conclusions of the results of this thesis.
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Chapter 2
Screening of asymptomatic patients 
with type 2 diabetes mellitus for silent 
coronary artery disease. Combined use of 
stress myocardial perfusion imaging and 
coronary calcium scoring
AJHA	Scholte,	JJ	Bax,	FJTh	Wackers










in	truly	asymptomatic	 individuals	with	diabetes	 is	about	20%	to	25%.	 It	 is	of	practical	
and	clinical	importance	to	explore	ways	to	“enrich”	the	target	screening	population.	In	
this	editorial	point	of	view	the	relative	roles	of	stress	radionuclide	myocardial	perfusion	











1.3 million individuals are diagnosed with diabetes each year.16 
Cardiovascular	complications,	including	coronary	artery	disease	(CAD),	are	the	leading	
causes of morbidity and mortality in individuals with type 2 diabetes mellitus.6 The over-
all	prevalence	of	CAD	has	been	reported	to	be	as	high	as	60%	in	patients	with	diabetes	
referred	for	stress	testing.17	The	10-year	mortality	rate	in	patients	with	known	CAD	and	







to improve the survival rate and may be superior to percutaneous coronary interven-






myocardial ischemia: exercise electrocardiography, stress myocardial perfusion imaging 
(MPI),	and	stress	echocardiography.	Other	noninvasive	techniques	may	be	able	to	detect	
the	generalized	process	of	atherosclerotic	disease,	such	as	imaging	of	the	vessel	wall	of	


















without	diabetes.	Giri	et	al	observed	 that	 the	cardiac	events	 rate	 in	diabetic	patients	
was	8.6%,	as	 compared	 to	4.5%	 in	non-diabetic	patients.20 As in the general popula-
tion,	stress	MPI	is	able	to	stratify	patients	with	diabetes	in	high-	and	low-risk	prognostic	






to be shorter than 2 years.20	It	is	conceivable	that	his	may	be	attributed	to	accelerated	
progression	of	atherosclerosis	in	the	diabetic	state.
MPI in asymptomatic patients with diabetes mellitus
Nesto	et	al	reported	in	1990	that	57%	of	asymptomatic	patients	with	diabetes	mellitus	
and	peripheral	vascular	disease	had	evidence	of	silent	CAD	on	stress	MPI.26 A number 
of	subsequent	studies	have	confirmed	the	presence	of	silent	ischemia	in	asymptomatic	
patients	with	diabetes.	19, 25-38 The reported prevalence of silent ischemia, however, var-
ied markedly between studies, from 6% to 59%.19, 30, 34, 36, 38-40 This wide range in the 








Screening for silent CAD 
bias,	the	first	type	of	study	in	the	literature	(section	A,	Table	2)	typically	showed	a	high	
prevalence	(41%-58%)	of	abnormal	stress	MPI	results	and	a	high	cardiac	event	rate.20, 22, 38 
It	 is	likely	these	patients	were	referred	for	stress	testing	because	of	typical	or	atypical	
symptoms and/or perceived clinical high risk. No details with regards to the type of dia-
betes	mellitus	or	its	treatment,	duration,	or	comorbidity	were	generally	available.	The	
second	type	of	studies	in	the	literature	(section	B,	Table	2)	showed	a	lower	prevalence	
of abnormal stress MPI and cardiac event rate.19, 25, 34, 37	Nevertheless,	these	patients	
may	not	be	representative	of	asymptomatic	patients	with	diabetes	in	the	larger	popula-
tion,	because	they	were	referred	for	stress	MPI,	for	example,	before	noncardiac	surgery.	
The mean prevalence of silent ischemia ranged from 26%-39%, although Miller et al 
reported	abnormal	MPI	in	59%	of	presumably	asymptomatic	patients.25 Because of the 
retrospective	nature	of	these	two	types	of	studies,	there	remains	uncertainty	about	the	
true	prevalence	of	silent	ischemia	in	asymptomatic	patients	with	diabetes.
Prospective studies in asymptomatic patients with diabetes mellitus
Several	prospective	studies	have	been	performed	in	truly	asymptomatic	patients	with	


















1987 Felsher21  123 201TL Exercise	 56 36 4.8 1.3
1999 Kang22 1271 201TL,MIBI Exercise,	Adenosine	 41 24±8 3.9-7.9 1.2
2002 Schinkel23  207 MIBI Dobutamine 64 49±29 6.6* 0.7*
2002 Giri20  929 201TL,MIBI Exercise,	Adenosine	 48 36±18 5.0-6.4 3.6-3.9
2003 Berman24 5333 201TL,MIBI Adenosine 37-62 27±9 4.7-9.0* 1.8-2.5
2004 Zellweger19  911 201TL,MIBI Exercise,	Adenosine 44-51 24 5.6-13.2 2.0-3.3
2004 Miller25 2998 201TL,MIBI Exercise,	Adenosine,	
Dipyridamole,	
Dobutamine
60 70±42 3.6-5.9 NA
F/U,	 follow-up;	HE,	 hard	 events	 (cardiac	 death	 or	 non-fatal	myocardial	 infarction);	MIBI,	 technetium-99m	 sestamibi;	MPI,	
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Screening for silent CAD 
may	explain	the	variation	in	observed	prevalence	of	silent	CAD.	For	example,	in	the	Milan	
Study	on	Atherosclerosis	and	Diabetes	(MiSAD)	asymptomatic	patients	with	diabetes	had	




performed either exercise electrocardiography or thallium-201 imaging, whereas Penfor-












Value of CAC scoring in patients with diabetes mellitus
CT	techniques	(EBCT,	multislice	CT)	allow	for	noninvasive	detection	and	quantification	of	
CAC,	an	early	marker	of	CAD.44	Various	studies	have	recently	demonstrated	the	prognos-
tic	significance	of	CAC	scores	in	the	general	population.45-48 Because of the previously 
mentioned	ominous	association	between	CAD	and	diabetes	mellitus,	the	prevalence	of	
CAC	has	been	explored	in	patients	with	diabetes	without	known	CAD.49 In a cohort study 
of	30,904	asymptomatic	 individuals,	 including	1,075	diabetics,	 the	median	CAC	 score	
was	 in	 general	 higher	 in	 patients	with	diabetes	 than	 in	 patients	without	diabetes.	 In	
addition,	 the	 likelihood	of	having	a	CAC	score	 in	 the	highest	age/gender	quartile	was	
70%	greater	for	patients	with	diabetes.	Raggi	et	al	investigated	the	prognostic	value	of	
CAC in subjects with and without diabetes mellitus.50 In a cohort of 10,377 asymptom-
atic	individuals,	which	included	903	diabetics,	the	mean	CAC	score	and	death	rate	were	
significantly	higher	in	subjects	with	diabetes	than	in	those	without	diabetes.	Moreover,	




evidence of CAC had a similar survival compared to that of individuals without diabetes 
and no detectable CAC. Qu et al noted that subjects with diabetes and low CAC score had 
a	four-fold	increase	in	hard	cardiac	event	rate	compared	with	nondiabetic	subjects	with	
a low CAC score.51	On	the	other	hand,	the	prognostic	value	of	CAC	as	a	continuum	was	
weaker	in	patients	with	diabetes	than	in	patients	without	diabetes.	
Elkeles	et	al	found	a	close	relationship	between	waist-hip	ratios,	systolic	blood	pressure	
and CAC score.52 Thus, CAC scoring may be linked to the metabolic syndrome in type 2 
diabetics.	In	asymptomatic	individuals,	Moser	et	al	noted	that	the	prevalence	of	CAC	was	
significantly	increased	when	more	than	3	cardiac	risk	factors	were	present.53 Thus, the 
presence	of	multiple	cardiac	risk	factors	could	be	used	as	a	justification	for	CAC	screen-
ing.	Furthermore,	an	Agatston	score	of	400	or	greater	appeared	to	be	a	logical	threshold	
for	initiating	further	testing	with	stress	MPI.53 These data suggest that CAC scoring may 
have	value	as	an	approach	to	enrich	target	population	of	asymptomatic	patients	with	
diabetes for screening.
Relative values of CAC score and ischemia on MPI for detecting CAD
Currently,	only	limited	data	are	available	on	the	relative	values	of	CAC	and	MPI	for	detec-
tion	silent	CAD	and	prognostication.	He	et	al	prospectively	examined	3,895	asymptomat-
ic	subjects	with	EBCT;	411	of	these	underwent	stress	MPI.54 Only 6.8% of these subjects 
had known diabetes mellitus. The likelihood of stress-induced myocardial ischemia on 
MPI	increased	in	parallel	to	the	CAC	score,	in	particular	at	CAC	scores	of	400	or	greater.	
Of	patients	with	CAC	score	400	or	greater,	46%	had	demonstrable	stress-induced	myo-
cardial ischemia on MPI. 
Berman	et	al	evaluated	1,195	patients	without	known	CAD,	including	51%	asymptomatic	
individuals	and	11.6	%	patients	with	diabetes.55 The authors noted that the likelihood 
of	stress-induced	myocardial	ischemia	on	MPI	was	very	low	(<2%)	if	the	CAC	score	was	
lower than 100 Agatston units. However, when the CAC score exceeded 400 Agatston 
units,	 a	 relatively	high	percentage	of	patients	had	abnormal	MPI	 studies.	 These	data	
suggested	a	 role	 for	CAC	 scoring	 as	 a	 gatekeeper	 for	patients	who	may	benefit	 from	
further	risk	stratification	with	stress	MPI.	Alternatively,	56%	of	patients	with	normal	MPI	
had	CAC	scores	of	100	and	greater,	indicating	that	absence	of	stress-induced	myocardial	
ischemia does not exclude preclinical presence of atherosclerosis.
Wong	et	al	 similarly	explored	 the	 interaction	between	CAC	 scoring	and	 stress	MPI	 in	
27
Screening for silent CAD 
1,043	patients	without	 known	CAD.56	Of	 the	patients,	 313	had	metabolic	 abnormali-
ties,	including	140	patients	with	diabetes	mellitus	and	173	patients	with	metabolic	syn-
drome. Again, a CAC score lower than 100, which occurred in approximately 2 % of pa-
tients,	was	associated	with	absence	of	stress-induced	ischemia	on	MPI.	The	likelihood	
of stress-inducible ischemia increased in parallel with increasing CAC score. It was noted 
that	 the	presence	of	 diabetes	mellitus	 or	metabolic	 syndrome	 significantly	 increased	







































ymptomatic	 patients	with	 diabetes	mellitus	 by	 stress	MPI	may	 not	 be	 cost	 effective.	
Moreover,	only	a	small	number	of	patients	may	have	severe	MPI	abnormalities.	Thus	it	
is	important	to	device	ways	to	enrich	the	target	population.	It	has	been	suggested	that	










atston score is lower than 100, the yield of stress MPI is likely to be low and may not 




cated. If stress MPI shows evidence of myocardial ischemia, coronary angiography is 
indicated.	If	stress	MPI	is	normal,	aggressive	medical	treatment	should	be	instituted	and	
stress MPI has to be repeated within two years. 
Prospective	studies	may	be	conducted	to	evaluate	the	effectiveness	of	such	a	screening	
approach	and	answer	the	following	questions:	Does	the	stepwise	approach	outlined	in	
the	algorithm	yield	higher	prevalence	of	 silent	CAD?	 Is	 the	outcome	 in	patients	with	
29
Screening for silent CAD 
low	CAC	 score	 indeed	 favourable?	Whether	 screening	and	early	detection	of	disease	
ultimately	result	in	improve	outcome	can	only	be	evaluated	in	a	large	randomized	treat-






















Different manifestations of coronary 
artery disease by stress speCt myocardial 
perfusion imaging, coronary calcium 
scoring and multislice CT coronary 
angiography in asymptomatic patients 
with type 2 diabetes mellitus
AJHA	Scholte,	JD	Schuijf,	AV	Kharagjitsingh,	P	Dibbets-Schneider,		
MPM	Stokkel,	JW	Jukema,	EE	van	der	Wall,	JJ	Bax,	FJTh	Wackers	






























served	 in	about	one-quarter	 to	one-fifth	by	each	modality,	either	 separately	or	 com-
bined.	The	relative	prognostic	value	of	each	modality	needs	to	be	determined	by	a	fol-
low-up of this cohort.
33
Different manifestations of CAD 
Introduction
Diabetes	mellitus	has	become	a	worldwide	healthcare	problem	and	its	prevalence	contin-
ues to increase.2, 16	Cardiovascular	complications	are	the	most	common	causes	of	mortal-






In	 the	DIAD	study	 the	overall	prevalence	of	 silent	myocardial	 ischemia	by	single-photon	
emission	computed	tomography	 (SPECT)	was	22%.	This	 included	stress-induced	regional	
myocardial	 perfusion	 abnormalities	 (16%)	 as	 well	 as	 ischemic	 electrocardiogram	 (ECG)	
changes	during	adenosine	infusion	or	abnormal	left	ventricular	function	(6%).36 Anand et al 
suggested	that	the	diagnostic	yield	of	screening	by	stress	SPECT	imaging	could	be	enhanced	
























for coronary heart disease.60 














MSCT angiography, interpreted reconstructed stress-rest short- and long-axis slices by visu-
al	analysis.	Images	were	categorized	as	either	normal	or	abnormal.	When	abnormal,	defect	
reversibility and stress defect severity were assessed using 17-segment colour-coded polar 










Different manifestations of CAD 










































and	2	patients	because	of	 an	uninterpretable	MSCT.	 Thus,	 the	final	 study	population	
consisted	of	100	patients	(65	men;	age,	53	±	10	years).	The	patient	characteristics	are	





SPECT myocardial perfusion imaging 
Twenty	patients	(20%)	had	regional	perfusion	abnormalities	(Figure	1).	Eighteen	of	these	
perfusion	abnormalities	were	reversible	defects.	Most	regional	perfusion	abnormalities	











Different manifestations of CAD 
MSCT coronary angiography 
MSCT	 coronary	 angiography	was	normal	 in	30	patients	 (30%).	 The	 remaining	70	pa-
tients	 (70%)	 showed	 luminal	narrowing	of	one	or	more	 coronary	arteries	 (Figure	1).	
Forty-six	had	nonobstructive	atherosclerosis,	11	had	single-vessel	 involvement	(24%),	
16	 had	 two-vessel	 involvement	 (35%)	 and	 19	 had	 three-vessel	 involvement	 (41%).	






Age	(yrs) 53 ± 10
Diabetes-related	risk	factors
Diabetes	duration	(yrs) 9.4 ± 7.0
Age	at	time	of	diagnosis	of	diabetes	(yrs) 44 ± 12.0




Insulin and oral agent 16	(16%)
Insulin 23	(23%)
Retinopathy 12	(12%)
Peripheral vascular disease* 14	(14%)
Body	mass	index	(kg/m2) 29 ± 5.0













ACE,	 angiotension	 converting	 enzyme;	ARB,	 angiotensin	 receptor	 blockers;	HbA1c, haemoglobin A1c;	 CAD,	 coronary	 artery	
disease;	yrs,	years;	kg,	kilogram;	m2,	square	meter.
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Figure 1.  Distribution	(%)	of	diagnostic	findings	on	stress	single-photon	emission	com-
puted	 tomography	 (SPECT),	 coronary	 artery	 calcium	 (CAC)	 scoring	 and	mul-
tislice	 computed	 tomography	 (MSCT)	 angiography	 in	 100	 asymptomatic	 pa-
tients	with	type	2	diabetes.	
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Abnormal	SPECT 12	(31%) 6	(14%) 5	(26%)
CAC	score	≥	401	AU 5	(13%) 8	(19%) 5	(26%)
MSCT	coronary	angiography	≥	50%	stenosis 4	(10%) 14	(33%) 6	(32%)
AU,	Agatston	units;	CAC	score,	coronary	artery	calcium	score;	MSCT,	multislice	computed	tomography;	SPECT,	single-photon	
emission computed tomography. 
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Chapter 3

























Figure 3.  	Ven	 diagram	 showing	 the	 interrelationship	 between	 abnormal	 stress	 SPECT,	
CAC	score	greater	than	or	equal	to	401	and	obstructive	(≥50%)	CAD	on	MSCT.	In	
17	patients	(17%)	more	than	2	diagnostic	tests	were	abnormal;	5	patients	had	
three abnormal test results.
CAC	score,	coronary	artery	calcium	score;	CAD,	coronary	artery	disease,	MSCT,	multislice	computed	tomography;	SPECT,	sin-







Different manifestations of CAD 














of coronary atherosclerosis by CAC and MSCT coronary angiography occurred more fre-




























prevalences are in the range of 22% prevalence of silent ischemia recently reported in a 
similar	patient	population	in	the	DIAD	study.36 
Several	 recent	 studies	 evaluated	 the	 interrelationship	 between	 abnormal	 SPECT	 im-





perfusion images did not exclude atherosclerosis.67 With	regards	to	CAC,	patients	with	
abnormal	SPECT	images	have	higher	likelihood	of	significant	CAC;	the	prevalence	of	an	
abnormal	 SPECT	 study	parallels	 the	 increasing	 severity	 of	 CAC	 score.55 However CAC 
(even	severe)	occurred	also	in	patients	with	normal	SPECT	images.55, 68 These observa-
tions	are	in	agreement	with	a	long-established	notion	that	no	tight	correlation	exists	be-
tween	apparently	anatomically	significant	CAD	and	stress-inducible	ischemia.	The	pres-
ent	 study	 illustrates	 similar	 inconsistent	 interrelationships	 in	Figure	3	and	4.	Possibly,	
plaque	extent,	 location	and	composition,	are	also	 important	predictors	of	 ischemia	 in	
addition	to	the	degree	of	stenosis	or	extent	of	coronary	artery	calcifications.	
The	studies	cited	above	were	performed	in	general	symptomatic	and	asymptomatic	pa-
tient	 cohorts	with	 known	or	 suspected	CAD.	How	 these	data	 apply	 to	 asymptomatic	
patients	with	diabetes	is	unclear.	Wong	et	al	showed	that	CAC	scores	greater	than	400	in	
patients	with	metabolic	syndrome	and	diabetes	indicated	markedly	increased	risk	for	in-









Different manifestations of CAD 
giography	to	CAC	observations	in	asymptomatic	patients	with	type	2	diabetes	showed	
that	CAD	was	present	in	55%	of	patients	with	CAC	<10,	indicating	the	presence	of	non-






























prevalence of coronary artery disease 
and plaque morphology assessed 
by multislice computed tomography 
coronary angiography and calcium scoring 






























type	2	diabetes.	A	 relatively	high	proportion	of	plaques	were	noncalcified	 (41%).	 Im-
portantly,	a	calcium	score	<	10	did	not	exclude	CAD	in	these	patients.	MSCT	might	be	
a	useful	technique	to	identify	CAD	in	asymptomatic	patients	with	type	2	diabetes	with	
incremental value over calcium scoring.
47
Prevalence of CAD and plaque morphology
Introduction
Diabetes	mellitus	 has	 reached	 epidemic	 proportions	 and	has	 become	 a	major	 public	
health problem. Almost 200 million individuals are known to have diabetes and this 
number	is	expected	to	increase	exponentionally.	In	the	USA	almost	1.3	million	new	sub-
jects are diagnosed with diabetes each year.16 
Cardiovascular	complications,	including	coronary	artery	disease	(CAD),	are	the	leading	
causes of morbidity and mortality in individuals with type 2 diabetes mellitus.6 The over-
all	prevalence	of	CAD	has	been	reported	to	be	as	high	as	60%	in	patients	with	diabetes	
referred	for	stress	testing.17	The	10-year	mortality	in	patients	with	known	CAD	and	dia-
betes exceeds 70%.7	The	poor	clinical	outcome	 in	patients	with	diabetes	underscores	
the	need	to	develop	practical	approaches	for	detecting	CAD	at	an	early	stage.	Moreover,	
in	patients	with	diabetes	mellitus,	CAD	has	frequently	progressed	to	an	advanced	state	
before it becomes clinically manifest.8, 9 
The	 role	 of	 single	 photon	 emission	 computed	 tomography	 (SPECT)	 in	 asymptomatic	
diabetics	 has	 recently	 been	 evaluated.	 The	 Detection	 of	 Silent	 Myocardial	 Ischemia	
in	Asymptomatic	Diabetics	 (DIAD)	 study	 is	 an	 ongoing	 randomized	 study	 using	 gated	





allows	anatomic,	noninvasive	 imaging	of	 the	coronary	arteries,	 including	detection	of	
coronary	atherosclerosis	by	assessing	the	coronary	artery	calcium	burden	(calcium	scor-















ment of cardiovascular risk. Inclusion criteria consisted of type 2 diabetes mellitus, no 
angina	 or	 angina-equivalent	 symptoms.	 Exclusion	 criteria	 were:	 known	 or	 suspected	





















cardiogram.	 Subsequently,	 data	 sets	were	 reconstructed	and	 transferred	 to	a	 remote	
workstation	as	previously	described.75	Briefly,	images	were	initially	reconstructed	at	75%	
of	the	cardiac	cycle.	In	case	of	motion	artefacts,	a	representative	single	slice	was	recon-
structed throughout the cardiac cycle in steps of 20 milliseconds to determine the most 
optimal	additional	reconstruction	phases.	
49
Prevalence of CAD and plaque morphology
MSCT, data analysis








a consensus decision was reached. Coronary arteries were divided into 17 segments ac-
cording	to	the	modified	American	Heart	Association	classification.66 Only segments with a 
diameter	>	1.5	mm	(as	measured	on	the	MSCT	coronary	angiogram)	were	included.	First,	
each	segment	was	classified	as	 interpretable	or	not.	Then,	 the	 interpretable	segments	






perform the analysis on a segmental basis, also in order to improve reproducibility of 
the	 results.	One	 coronary	 plaque	was	 assigned	 per	 segment.	 Subsequently,	 the	 type	
of	 plaque	was	 determined	 using	 the	 following	 classification:	 1)	 noncalcified	 plaques,	



















110 ± 88 months.
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Age	(yrs)  54 ± 11
Gender	(male) 	 52	(74%)
BMI(kg/m2)  29 ± 5
Circumferential	length	(cm) 101 ± 13
Age	at	diabetes	diagnosis	(yrs)  45 ± 12






Creatinine	(μmol/L)  84 ± 20
HbA1C	(%)   7.2 ± 1.6




Oral agent 	 44	(63%)
Insulin plus oral agent 	 11	(16%)
ACE	inhibitors 	 24	(34%)
AT-2 blockers 	 15	(21%)
Statins	 	 33	(47%)
Aspirin 	 16	(23%)
DM related complications 	 37	(53%)













































Prevalence of CAD and plaque morphology
Coronary calcium score versus coronary angiography
Comparison of the coronary artery calcium score and MSCT angiography showed that 
the	percentage	of	patients	with	obstructive	CAD	paralleled	the	increasing	calcium	score;	































Two	 recent	 studies	 used	 nuclear	 imaging	with	 SPECT	 and	 showed	 a	 prevalence	 of	
(silent)	myocardial	ischemia	ranging	from	18%	to	22%	in	truly	asymptomatic	patients	
with type 2 diabetes.36, 43	 However,	 SPECT	 reflects	 only	 indirectly	 the	 presence	 of	
CAD,	since	it	is	based	on	the	detection	of	coronary	lesions	that	result	in	compromised	
blood	flow	during	stress,	whereas	the	actual	prevalence	of	any	atherosclerosis	in	as-
ymptomatic	 patients	with	 diabetes	mellitus	may	 be	 higher.	 Indeed,	 in	 the	 current	
study	with	MSCT,	CAD	was	observed	 in	80%	of	 asymptomatic	patients	with	 type	2	
diabetes	mellitus.	Furthermore,	the	majority	of	patients	showed	diffuse	involvement	
of all three coronary arteries. The high prevalence of coronary atherosclerosis among 
diabetic	patients	without	clinical	CAD	has	been	defined	previously	in	a	large	autopsy	
cohort of 293 decedents.76	In	line	with	the	current	observations,	coronary	atheroscle-
rosis	was	observed	in	almost	75%	of	individuals	with	50%	having	diffuse	multi-vessel	
CAD.
Noninvasively, calcium scoring has been proposed to determine the prevalence of 
atherosclerosis.	Previous	studies	 in	the	general	population	have	demonstrated	that	
















































relevance since clinical outcome may considerably improve if aggressive medical ther-
apy	is	initiated	at	an	early	stage.	Screening	of	asymptomatic	diabetic	patients	however,	




whether calcium scoring with or without MSCT angiography has a role in this process, 
needs to be addressed in large future studies. 
Limitations
Several	limitations	should	be	mentioned.	First,	only	a	limited	number	of	patients	were	

















prevalence and predictors of an abnormal 
stress myocardial perfusion study in 









The purpose of this study was to evaluate the prevalence of an abnormal stress myocar-
dial	perfusion	study	in	a	cohort	of	truly	asymptomatic	patients	with	type	2	diabetes	mel-


















fusion	abnormalities	 in	30	patients	 (25%).	 In	10	 (8%)	patients,	 indicators	of	extensive	
(possibly	balanced	ischemia)	were	observed	in	the	absence	of	abnormal	perfusion.	The	
multivariable	analysis	identified	current	smoking,	duration	of	diabetes	and	cholesterol/	
high-density	 lipoprotein	 (HDL)	 ratio	 as	 independent	 predictors	 of	 an	 abnormal	 stress	
study.	During	a	 follow-up	period	of	12	months	 six	 (5%)	patients	had	a	 cardiovascular	
event.
Conclusion










tus, cardiovascular diseases are a major cause of mortality and morbidity, with coronary 
artery	disease	(CAD)	being	the	leading	cause	of	death.6 Moreover, atherosclerosis and 
CAD	appear	to	develop	differently	in	patients	with	diabetes	as	compared	to	nondiabetic	
individuals.	 Frequently,	CAD	develops	at	a	 younger	age	and	 shows	 faster	progression	
without the development of symptoms.8, 9	Consequently,	subclinical	or	silent	myocardial	
ischemia	is	frequently	present	in	patients	with	diabetes,	yet	difficult	to	detect	as	a	re-
sults of the absence of symptoms. 
To	improve	identification	of	diabetic	patients	at	high	risk	for	cardiovascular	events,	as-
sessment of myocardial perfusion by means of single photon emission computed tomog-








of	CAD	and	a	 cardiovascular	event,	 thereby	 increasing	 the	yield	of	abnormal	 studies.	
Accordingly,	clinical	predictors	are	needed	to	identify	those	patients	with	a	higher	likeli-
hood of silent myocardial ischemia. 

















of	 coronary	 revascularization,	 treatment	with	 antianginal	medication,	 electrocardio-









weight per minute for 6 minutes with a simultaneous handgrip exercise. Blood pressure 



























ered	present	 if	 SRS	≥2	and	SDS	<2.	Perfusion	defects	were	allocated	 to	 the	 coronary	
artery	territories	 (left	descending,	 left	circumflex	and	right	coronary	arteries).87 Using 
the	gated	images,	regional	wall	motion	was	analyzed	to	improve	differentiation	between	







the	LV	were	categorized	as	abnormal.36, 89, 90 Finally,	flat	or	down-sloping	ST-segment	
depression	≥1	mm	at	80	ms	after	the	J-point	in	two	or	more	leads	on	the	ECG	during	
adenosine infusion was also interpreted as an abnormal test result.63 Thus, an abnormal 
vasodilator	stress	SPECT	myocardial	perfusion	imaging	study	was	defined	as;	1	abnormal	
myocardial	perfusion,	2	LVEF	<	45	%,	3	TID,	4	increased	lung	uptake	and	5	ischemic	ST	
depression during adenosine infusion. 
follow-up




diac	death,	 (2)	nonfatal	myocardial	 infarction,	 (3)	unstable	angina	 requiring	hospi-
talization,	 (4)	 revascularization,	 or	 (5)	 stroke.	 Cardiac	 death	was	 defined	 as	 death	
caused	by	acute	myocardial	 infarction,	ventricular	arrhythmias,	or	refractory	heart	
failure.	Nonfatal	myocardial	infarction	was	defined	based	on	criteria	of	typical	chest	




Categorical	 baseline	 characteristics	 are	 expressed	 as	 numbers	 and	 percentages,	 and	
compared	between	two	groups	with	the	chi-square	test.	Continuous	variables	are	ex-





















Prevalence and predictors of abnormal MPS
table 1.  Patient	characteristics;	comparison	between	patients	with	normal	and	abnor-








Male 75	(62) 23	(58) 52	(65) 0.42
Female 45	(38) 17	(42) 28	(35) 0.42
Age	(years) 53±10 53±10 53±10 1.00
Diabetes-related	risk	factors
Duration	(years) 9.5±7.3 11.8±8.4 8.3±6.4 0.03
Age	at	time	of	diagnosis	of	diabetes	(years) 43±12 41±13 45±10 0.05
HbA1C 7.3±1.6 7.5±1.6 7.3±1.6 0.39
Treatment
Oral 70	(59) 20	(50) 50	(63) 0.19
Insulin and oral 18	(15) 66	(15) 12	(15) 0.98
Insulin 29	(24) 13	(33) 16	(20) 0.14
Peripheral	vascular	disease	(PVD) 12	(10) 5	(13) 7	(9) 0.52
Peripheral	neuropathy	(PNP) 25	(21) 7	(18) 18	(23) 0.53
Peripheral vascular and neuropathy 17	(14) 9	(23) 8	(10) 0.06
Body	mass	index	(kg/m2) 29.1±5.4 29.0±4.5 29.1±5.7  0.92
Waist	circumference	(cm) 103±14 104±14 102±14 0.66
Hypertension 65	(54) 23	(58) 42	(53) 0.60
Hypercholesterolemia 68	(57) 27	(68) 41	(51) 0.90
Family	history	of	CAD 65	(54) 18	(45) 47	(59) 0.15
Smoking
Past 25	(21) 5	(13) 20	(25) 0.11
Current 27	(23) 16	(40) 11	(14) 0.001
Medication
Aspirin 27	(23) 9	(30) 16	(20) 0.35
ACE	inhibitors 42	(35) 14	(35) 28	(35) 1.0
ARB 27	(23) 14	(25) 17	(21) 0.64
Statins 68	(57) 27	(68) 41	(51) 0.09
Serum markers
Total	cholesterol	(mmol/l) 4.8±1.2 4.5±1.3 4.9±1.1 0.09
LDL	(mmol/l) 3.1±1.1 3.0±1.3 3.1±1.0 0.45
HDL	(mmol/l) 1.4±0.6 1.5±0.5 1.4±0.6 0.48
Triglycerides	(mmol/l) 2.0±1.2 1.8±0.9 2.1±1.4 0.24
Cholesterol/HDL	ratio 3.7±1.3 3.4±1.0 3.9±1.4 0.03
Creatinine	(mmol/l) 77.6±20.1 75.2±20.0 78.8±20.2 0.36
Urine	albumin-creatinine	ratio 11.6±30.2 10.3±26.0 12.4±32.5 0.75
CRP 9.3±9.1 11.1±12.7 8.2±6.1 0.26
ApoA1 1.4±0.2 1.5±0.2 1.1±0.3 0.51
ApoB 0.9±0.3 0.8±0.3 0.9±0.3 0.16





prevalence of an abnormal stress myocardial perfusion study 
Perfusion abnormalities
Regional	perfusion	abnormalities	were	present	in	30	patients	(25%).	Of	these	patients	













In	 patients	with	 perfusion	 abnormalities,	mean	 LVEF,	 EDV	 and	 ESV	were	 respectively	
58.0 ± 12.6%, 85.0 ± 29.0 ml and 37.9 ± 22.6 ml at rest and 57.5% ± 12.8%, 90.0 ± 37.0 ml 
and	41.8	±	28.2	ml	during	stress.	Eight	patients	had	LV	dysfunction	at	rest	(LVEF	<45%),	
of	which	4	patients	also	showed	abnormal	perfusion.











































table 2. Univariable predictors of an abnormal stress myocardial perfusion study.
Odds ratio 95% confidence interval P value 
Gender	(M/F) 0.73 1.59-0.34 0.42
Age	(years) 1.00 0.96-1.04 1.00
Diabetes-related	risk	factors
Duration	(years) 1.07 1.01-1.13 0.02
Age	at	time	of	diagnosis	of	diabetes	(years) 0.97 0.93-1.00 0.05
HbA1C 1.11 0.87-1.42 0.39
Treatment
Oral 1.67 0.77-3.59 0.19
Insulin and oral 1.02 0.35-2.94 0.98
Insulin 0.53 0.22-1.25 0.15
Peripheral	vascular	disease	(PVD) 0.67 0.20-2.27 0.52
Peripheral	neuropathy	(PNP) 0.73 0.28-1.93 0.57
Peripheral vascular and neuropathy 2.61 0.92-7.40 0.07
Body	mass	index	(kg/m2) 1.00 0.93-1.07 0.92
Waist	circumference	(cm) 1.01 0.98-1.04 0.65
Hypertension 1.22 0.57-2.63 0.61
Hypercholesterolemia 0.09 0.89-4.37 0.09
Family	history	of	CAD 0.57 0.27-1.24 0.16
Smoking
Past 0.43 0.15-1.24 0.12
Current 4.18 1.71-10.26 0.02
Medication
Aspirin 1.52 0.63-3.67 0.36
ACE	inhibitors 1.00 0.45-2.22 1.00
ARB 1.24 0.51-3.02 0.64
Statins 1.98 0.89-4.37 0.09
Serum markers
Total	cholesterol	(mmol/l) 0.75 0.53-1.06 0.10
LDL	(mmol/l) 0.87 0.61-1.24 0.45
HDL	(mmol/l) 1.27 0.66-2.48 0.48
Triglycerides	(mmol/l) 0.81 0.56-1.16 0.25
Cholesterol/HDL	ratio 0.69 0.49-0.97 0.03
Creatinine	(mmol/l) 0.95 0.87-1.02 0.15
Urine	albumin-creatinine	ratio 1.00 0.98-1.01 0.75
CRP 1.04 0.97-1.11 0.29
ApoA1 1.72 0.34-8.53 0.51
ApoB 0.33 0.07-1.55 0.16




Prevalence and predictors of abnormal MPS














prevalence of abnormal stress myocardial perfusion study indicative for cardiovascular 
disease 
Various	studies	have	evaluated	the	prevalence	of	silent	myocardial	 ischemia	in	both	
retrospective	 and	 prospective	 settings.	 Studies	 using	 nuclear	 imaging	 to	 assess	 the	
prevalence	of	 ischemia	 in	asymptomatic	diabetic	patients	have	shown	perfusion	ab-
normalities	 in	6%	 to	59%	of	patients.19, 25-38	Most	 likely,	 these	widely	differing	esti-
mates	of	CAD	in	asymptomatic	patients	reflect	differences	in	study	design	and	inclu-
sion	criteria.	In	the	investigation	by	Miller	et	al	a	high	prevalence	of	abnormal	stress	
SPECT	 studies	 (59%	of	 patients)	was	 reported.	However,	 in	 this	 retrospective	 study	
also	patients	with	anti-anginal	medication	and	Q	waves	and	ST-T	abnormalities	on	the	
table 3. Multivariable	logistic	regression	analysis
Odds ratio 95% confidence interval P value
Current smoker 7.12 2.51-20.23 <0.001
Cholesterol/HDL	ratio 0.60 0.41-0.89 0.01
Duration	diabetes 1.07 1.01-1.13 0.02
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diabetes care center. The stress myocardial perfusion study was abnormal in 40 pa-
tients	(33%),	 including	20	patients	(17%)	with	moderate	to	severe	 ischemia.	Slightly	
lower	values	were	reported	in	the	DIAD	trial	by	Wackers	et	al.	The	DIAD	trial	evaluated	
prospectively	silent	myocardial	 ischemia	 in	522	asymptomatic	patients	with	at	 least	
two risk factors, by using gated 99mTc	MIBI	SPECT.36 This study showed a prevalence 
of	22%	abnormal	SPECT	studies,	including	markedly	abnormal	perfusion	images	with	
moderate	or	large	stress	defects	in	33	patients	(6%).




patients	were	 insulin	 dependent	 and	 a	 higher	 percentage	 of	 patients	were	 current	
smokers,	factors	which	are	in	general	associated	with	more	advanced	CAD.	




study. In contrast, none of the established risk factors could predict abnormal myocardial 
perfusion	in	the	DIAD	trial,	except	for	cardiac	neuropathy.	Also	in	another	prospective	






Prevalence and predictors of abnormal MPS
Clinical implications
At	present,	screening	 for	CAD	 in	asymptomatic	patients	with	diabetes	 type	2	 is	still	a	
heavily debated topic.82, 83	Nevertheless,	this	population	may	benefit	from	identification	
of silent myocardial ischemia since clinical outcome may be considerably improved by 
initiation	of	aggressive	therapy	at	an	early	stage	as	recently	shown	by	Wackers	et	al.92
However,	 as	 the	 overall	 percentage	 of	 asymptomatic	 diabetic	 patients	with	 ischemia	




proposed. The presence of coronary calcium is a direct marker for coronary atheroscle-
rosis,	and	can	be	relatively	easily	assessed.	In	the	general	population,	several	investiga-
tions	have	demonstrated	a	strong	relation	between	increasing	coronary	calcium	scores	







related	well	with	 the	 prevalence	 and	 severity	 of	myocardial	 perfusion	 abnormalities.	
Moreover,	patients	with	extensive	calcium	(calcium	score	>400)	were	shown	to	have	a	
high	 likelihood	 (48%)	of	myocardial	 ischemia	while	patients	without	considerable	cal-
cium	(calcium	score	<100)	the	likelihood	of	ischemia	was	low	(18%).	Finally,	the	calcium	
score	was	demonstrated	to	be	superior	to	the	established	risk	factors	in	predicting	silent	
ischemia and cardiac events.
Importantly	however,	severe	calcifications	have	also	been	observed	in	patients	with	nor-










































Finally,	while	myocardial	 ischemia	due	 to	CAD	 is	 the	main	cause	of	 LV	dysfunction	 in	
73












The difficulty of adequate risk 








two years ago. Other risk factors for coronary artery disease included hypercholesterol-
emia, smoking and a family history of coronary artery disease. 
The	patient	was	asymptomatic.	Physical	examination	was	unremarkable;	his	body	mass	













Risk stratification in asymptomatic diabetics
Figure 2.  SPECT	myocardial	perfusion	 imaging	showing	normal	perfusion	at	stress	and	
rest.	 Short-axis	 (SAX),	 vertical	 long-axis	 (VLA)	 and	 horizontal	 long-axis	 (HLA)	
slices	are	shown.	The	top	rows	are	the	stress	images,	and	the	bottom	rows	are	
the rest images. 
nary	angiography	revealed	the	presence	of	diffuse	nonobstructive	(<50%	luminal	nar-
rowing),	 noncalcified	 plaques	 as	 illustrated	 in	 Figure	 3.	 Risk	 factor	 modification	 was	
advised	(exercise,	stop	smoking)	and	aggressive	medical	therapy	was	initiated	(aspirin,	
statins,	ACE	inhibitor).













On	 the	basis	of	 these	 imaging	 results,	 the	patient	was	 referred	 for	 invasive	 coronary	











diovascular	 events,	 and	 invasive	 evaluation	 (with	 possible	 intervention)	 is	 needed.	
Figure 3.  Noninvasive coronary angiography with 64-slice computed tomography re-
vealed	 the	presence	of	noncalcified	atherosclerosis	with	predominantly	out-
ward remodelling. In the mid-segment of the right coronary artery a large non-
calcified	 lesion	without	 significant	 stenosis	 (arrow)	was	 detected	 (A).	 Cross-
sectional	 images	 (B,	 enlargement	 C)	 confirmed	 the	 presence	 of	 substantial	
noncalcified	plaque	(arrows)	which	showed	predominantly	outward	remodel-
ling without compromising the vessel lumen.
79
Risk stratification in asymptomatic diabetics
This	patient	however	had	normal	myocardial	perfusion	imaging	results	while	at	stress	
and rest.
More	 recently,	 techniques	 have	 become	 available	 that	 permit	 early	 identification	 of	
atherosclerosis	 (calcium	scoring),	and	also	provide	preliminary	 information	on	plaque	
composition	 (multislice	 computed	 tomography	 angiography).	 In	 this	 patient,	 calcified	
plaques	were	not	present,	but	noncalcified	lesions	were	observed.	Recent	preliminary	
data	indicate	that	noncalcified	plaques	are	associated	with	acute	coronary	syndromes	



















Subclinical left ventricular dysfunction and 
coronary atherosclerosis in asymptomatic 








The	presence	of	 subclinical	 left	ventricular	 (LV)	dysfunction	 in	 asymptomatic	patients	
with type 2 diabetes has been previously described. However, whether there is a link 
between	subclinical	LV	dysfunction	and	subclinical	coronary	atherosclerosis	is	unknown.	
Accordingly,	the	aim	of	the	present	study	was	to	evaluate	whether	subclinical	LV	systolic	











pared	 to	patients	without	 coronary	 atherosclerosis	 (CAC=0)	 (n=95)	 (-18.0	 ±	 2.8 % vs. 










Subclinical left ventricular dysfunction 
Introduction
Cardiovascular	complications,	including	coronary	artery	disease	(CAD),	are	the	leading	







invasive imaging of the coronary arteries, by means of MSCT coronary angiography, and 
myocardial perfusion imaging, by means of single photon emission computed tomog-
raphy	(SPECT),	have	been	recently	proposed	to	improve	identification	of	asymptomatic	
diabetic	patients	at	high-risk	for	cardiovascular	events.36, 43, 84 
Recently,	subtle	abnormalities	of	 left	ventricular	(LV)	systolic	 function	have	been	re-
ported	 in	 patients	with	 type	 2	 diabetes	 using	 automated	 function	 imaging	 (AFI),	 a	




is independently related to coronary atherosclerosis and if it could provide incremen-
tal	 information	 over	 baseline	 characteristics	 for	 the	 identification	 of	 asymptomatic	
diabetic	patients	having	CAD.	AFI	was	used	to	identify	the	presence	of	subclinical	LV	
systolic	dysfunction,	while	the	presence	of	coronary	atherosclerosis	was	assessed	by	























on the same day. 







CAC	score	was	calculated	for	each	patient	using	the	Agatston	method.99 The presence of 
coronary	atherosclerosis	was	defined	as	a	CAC	score	>0.
Two‑dimensional echocardiography, data acquisition and analysis








Subclinical left ventricular dysfunction 









DT = 160-240	ms	and	PVs	≥	PVd.103	The	LV	global	 left	ventricular	 strain	 (GLS)	was	as-
sessed	offline	(Echo	PAC	version	7.0.0)	using	AFI	as	previously	described.14, 104	The	soft-









systolic frame in each apical view, the automated algorithm traces 3 concentric lines on 
the endocardial border, the mid-myocardial layer and epicardial border, including the 
entire	myocardial	wall.	The	tracking	algorithm	follows	the	endocardium	from	this	single	
frame throughout the cardiac cycle, and allows for a further manual adjustment of the 
region of interest to ensure that all myocardial regions are included throughout the car-
diac	cycle.	The	LV	is	divided	in	6	segments	in	each	apical	view	and	the	tracking	quality	is	

















among groups were performed using the one-way analysis of variance test with Bonfer-


























Subclinical left ventricular dysfunction 
table 1.  Clinical	and	echocardiographic	characteristics	of	the	study	population	in	rela-
tion	to	coronary	atherosclerosis
overall Coronary atherosclerosis p value
n=234 CaC score = 0
 (n=95)           
CaC score > 0
(n=139)
Age	(years) 52 ± 11 46 ± 11 56 ± 10 <0.001
Male	gender,	n	(%) 134	(57) 42	(44) 92	(66) 0.01
Hypertension,	n	(%)* 133	(57) 34	(36) 37	(58) <0.001
Smoking,	n	(%) 54	(23) 18	(19) 36	(26) 0.22
Hypercholesterolemia,	n	(%)	# 143	(61) 44	(46) 99	(71) <0.001
Positive	family	history,	n	(%) 113	(48) 43	(45) 70	(50) 0.44
Diabetes-related	risk	factors
Diabetes	duration	(years) 13 ± 11 10 ± 8 14 ± 12 <0.001
Age	at	time	of	diagnosis	DM	(years) 40 ±15 36 ± 13 42 ± 15 0.08
HbA1C	(%) 7.8 ± 1.7 7.7 ± 1.6 7.9 ± 1.7 0.57
Treatment,	n	(%)
Oral 89	(38) 35	(37) 54	(39) 0.76
Insulin 97	(42) 35	(37) 54	(39) 0.66
Insulin and oral agent 42	(18) 15	(16) 27	(19) 0.48
Retinopathy,	n	(%) 48	(21) 11	(12) 37	(27) 0.005
Nephropathy 32	(14) 9	(9) 23	(17) 0.12
PVD,	n	(%) 33	(14) 11	(12) 22	(16) 0.36
PNP,	n	(%) 89	(38) 23	(24) 66	(48) <0.001
Body	mass	index	(kg/m2) 28 ± 6 28 ± 6 28 ± 5 0.73
Waist	circumference	(cm) 100 ± 14 98 ± 14 101 ±14 0.14
Medication,	n	(%)
Aspirin 53	(23) 11	(12) 42	(30) 0.001
ACE-inhibitors 70	(30) 12	(13) 58	(42) <0.001
Statins 118	(50) 31	(33) 87	(63) <0.001
Serum markers
Total	cholesterol	(mmol/l) 4.7 ± 1.1 4.6 ± 1.0 4.8 ± 1.2 0.12
LDL	(mmol/l) 3.0 ± 1.0 2.9 ± 1.0 3.0 ± 1.0 0.39
HDL	(mmol/l) 1.4 ± 0.6 1.4 ± 0.5 1.4 ± 0.6 0.55
Cholesterol/HDL	ratio 3.6 ± 1.3 3.5 ± 1.2 3.8 ± 1.3 0.07







overall Coronary atherosclerosis p value
n=234 CaC score = 0
 (n=95)           
CaC score > 0
(n=139)
Two-dimensional echocardiography
LV	ejection	fraction	(%) 68 ± 10 68 ± 9 68 ± 11 0.90
LV	enddiastolic	volume	(ml) 118 ± 29 117 ± 25 119 ± 32 0.72
LV	endsystolic	volume	(ml) 39 ± 17 38 ± 14 39 ± 19 0.69
E	wave	(m/sec) 0.71 ± 0.18 0.75 ± 0.21 0.69 ± 0.16 0.06
A	wave	(m/sec) 0.69 ± 0.19 0.66 ± 0.18 0.72 ± 0.19 0.04
E/A 1.08 ± 0.35 1.20 ± 0.41 1.00 ± 0.29 <0.001
DT	E	Wave	(msec) 179 ± 55 175 ± 46 181 ± 61 0.38
PVs	(m/sec) 0.52 ± 0.11 0.52 ± 0.11 0.52 ±0.12 0.87
PVd	(m/sec) 0.41 ± 0.10 0.43 ± 10 0.40 ± 0.10 0.05
PV	s/d 1.30 ± 0.35 1.26 ± 0.32 1.34 ± 0.36 0.08
E’	(cm/sec) 6.37 ± 2.13 7.05 ± 2.34 5.89 ± 1.83 <0.001
E/E’ 12.56 ± 6.73 12.16 ± 6.67 12.84 ± 6.78 0.45
LV	diastolic	dysfunction,	n	(%) 158	(68) 53	(23) 105	(45) 0.002
LV	mass	index	(g/m2) 83 ± 22 80 ± 19 85 ± 24 0.07




* Blood pressure >140/90	mm	Hg	or	treatment	with	antihypertensive	medication,	#total	cholesterol	level	>5.0	mmol/L	or	use	
of	cholesterol	lowering	medication
Table1.  continued
Regarding	 the	 echocardiographic	 characteristics,	 the	 LVEF	 was	 within	 normal	 limits	
(68 ± 10%)	and	the	LV	mass	index	was	83 ± 22 g/m2.	The	mean	GLS	was	-17.0 ± 3.0%.
Diastolic	dysfunction	was	observed	in	158	(68%)	patients.






sclerosis	 had	 more	 frequently	 hypertension,	 hypercholesterolemia,	 retinopathy	 and	
polyneuropathy	(p	<0.01	for	all	comparisons).	
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dent predictors for coronary atherosclerosis
univariable Multivariatble
or (95% Ci) p value or (95% Ci) p value
Age	(years) 1.10	(1.06-1.13) <0.001 1.04	(0.91-1.18) 0.61
Male 2.47	(1.45-4.22) 0.001 2.70	(1.36-5.36) 0.005
Hypertension 4.44	(2.54-7.75) <0.001 2.58	(1.30-5.13) 0.007
Smoking 1.51	(0.73-2.86) 0.21 - -
Family	history	of	CAD 1.23	(0.73-2.07) 0.44 - -
Hypercholesterolemia 2.94	(1.70-5.09) <0.001 2.41	(1.26-4.63) 0.016
Diabetes	duration	(years) 1.04	(1.01-1.08) 0.003 1.10	(0.96-1.25) 0.17
Age	at	time	of	diagnosis	DM	(years) 1.03	(1.01-1.04) 0.006 1.10	(0.92-1.20) 0.45
HbA1C	(%) 1.088	(0.93-1.28) 0.31 - -
Retinopathy	 2.77	(1.33-5.76) 0.006 1.80	(0.67-4.90) 0.24
Nephropathy 1.90	(0.84-4.30) 0.13 - -
PVD 1.44	(0.66-3.12) 0.36 - -
PNP 2.83(1.59-5.03) <0.001 1.69	(0.82-3.50) 0.16
LV	mass	index	(g/m2) 1.01	(1.00-1.02) 0.07 - -
LV	ejection	fraction	(%) 1.00	(0.97-1.03) 0.91 - -
Diastolic	dysfunction 2.45	(1.40-4.28) 0.002 0.71	(0.33-1.51) 0.37
LV	GLS	(%) 1.23	(1.11-1.30) <0.001 1.20	(1.07-1.36) 0.003
CAD,	coronary	artery	disease;	CI,	confidence	interval;	DM,	diabetes	mellitus;	GLS,	global	longitudinal	strain;	LV,	left	ventricular;	
OR,	odds	ratio;	PNP,	peripheral	neuropathy;	PVD,	peripheral	vessel	disease.




Diabetes study population 
(n=234)
p value
Age	(years) 54 ± 8 52 ± 11 0.15
Male	(%) 37	(46%) 134	(57) 0.09
LV	ejection	fraction	(%) 66 ± 5 68 ± 10 0.21
Framingham	risk	score 11 ± 6 12 ± 9 0.12
LV,	left	ventricular
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Subclinical left ventricular dysfunction 
occur,	diffuse	multi-vessel	atherosclerosis	is	frequently	present.	It	has	been	shown	that	
risk	and	mortality	from	CAD	in	patients	with	type	2	diabetes	are	similar	to	patients	with-
out	diabetes	and	previous	myocardial	 infarction,	 indicating	increased	event	risk	 in	dia-
betic	patients.7 In	addition,	CAD	is	one	of	the	main	causes	of	overt	LV	dysfunction	and	
heart	failure	in	this	group	of	patients.106	Accordingly,	early	identification	of	coronary	
atherosclerosis	 in	 asymptomatic	diabetics	may	be	beneficial,	 allowing	timely	detec-
tion	of	patients	at	increased	risk,	and	appropriate	selection	of	further	diagnostic	and	
therapeutic	procedures.	 In	 the	present	 study,	noninvasive	assessment	of	CAC	score	
was	performed	 in	a	 large	cohort	of	asymptomatic	patients	with	type	2	diabetes	 for	
CAD	screening	purpose;	moreover,	conventional	transthoracic	echocardiography	and	
speckle-tracking echocardiography were performed to evaluate the presence of dia-
stolic	and	subclinical	systolic	dysfunction,	 respectively.	The	relationship	between	LV	
dysfunction	 and	 subclinical	 coronary	 atherosclerosis	 was	 then	 evaluated.	 Previous	
studies	in	the	general	population	have	demonstrated	that	the	extent	of	CAC	strongly	
correlates	with	 the	 overall	magnitude	 of	 atherosclerotic	 plaque	 burden.107, 108 The 
extent	of	CAC	 is	affected	by	age,	gender,	and	traditional	cardiovascular	 risk	 factors.	
A	threshold	value	of	400	as	the	cut-point	for	high	risk	for	obstructive	CAD	has	been	




dysfunction	was	 frequently	 observed	 in	 diabetic	 patients	 (68%)110-116;	 of	 note,	 the	
prevalence	of	diastolic	dysfunction	was	higher	in	diabetics	with	as	compared	to	those	
without	coronary	atherosclerosis	(45%	versus	23%).	More	interestingly,	GLS	(i.e.	ac-






Previous	 studies	 have	 underscored	 the	 presence	 of	 subclinical	 LV	 dysfunction	 in	
a	symptomatic	 patients	with	 type	 2	 diabetes.117-119 The underlying pathophysiology 
of	 diabetic	 cardiomyopathy	 includes	 several	 processes	 that	 act	 synergistically	 and	
hyperglycemia	 is	considered	as	the	central	 factor	that	 triggers	several	adaptive	and	





endothelial	 dysfunction.	 The	 subendocardial	 fibers,	 oriented	 longitudinally,	 are	 the	
first	to	be	involved	in	these	processes	and,	therefore,	subclinical	LV	systolic	dysfunc-
tion	 can	 be	 identified	with	 the	 assessment	 of	 LV	 GLS.	 A	 reduced	 GLS	 indicates,	 at	






sclerosis.	 Small	 vessel	micro-embolization,	 endothelial	 dysfunction	 or	 chronic	 isch-
emia may indeed induce subclinical myocardial damage. This may lead to decreased 
GLS	of	 the	 longitudinal	 fibers,	which	 are	more	 susceptible	 to	 ischemia	 and	 explain	
the	observations	by	the	current	study.121	Interestingly,	similar	data	have	been	previ-
ously	 reported	by	other	authors	 in	different	 study	populations,	partially	 supporting	
the	present	findings.	Stein	and	co-workers,	for	instance,	observed	a	relation	between	

















Subclinical left ventricular dysfunction 
To	improve	the	identification	of	diabetic	patients	at	high	risk	of	cardiovascular	events,	
SPECT	 myocardial	 perfusion,	 CAC	 score	 and	 MSCT	 coronary	 angiography	 has	 been	
proposed.36, 43, 84, 124	However,	 these	 techniques	may	be	 limited	available	and	associ-













autonomic neuropathy by 
123i metaiodobenzylguanidine 
myocardial scintigraphy and heart rate 
variability in asymptomatic patients 








The purpose of this study was to evaluate the prevalence of cardiac autonomic neuropa-
thy	(CAN)	in	a	cohort	of	truly	asymptomatic	patients	with	type	2	diabetes	mellitus	using	
















mellitus.	Secondly,	disagreement	between	HRV	and	 123I-mIBG	scintigraphy	 for	 the	as-
sessment of CAN was observed.
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litus	 type	2	often	 suffer	 from	CAD	without	 symptoms,	 risk	 stratification	 is	 needed	 to	
identify	patients	at	high	risk	for	CAD.	In	the	DIAD	(Detection	of	silent	myocardial	Isch-
emia	in	Asymptomatic	Diabetic	subjects)	study	the	overall	prevalence	by	single	photon	
emission	computed	tomography	 (SPECT)	of	silent	myocardial	 ischemia	was	22%.36 Al-
though	traditional	risk	factors	failed	to	predict	silent	myocardial	ischemia,	cardiac	auto-
nomic	neuropathy	(CAN)	assessed	by	heart	rate	variability	(HRV),	was	a	strong	predictor	
for	silent	myocardial	 ischemia	 in	this	study.	Furthermore,	 it	 is	known	that	CAN	is	one	
of	the	most	common	diabetes-associated	complications	and	has	been	associated	with	
increased risk of mortality and major cardiovascular events.125-129 However, although 
CAN	assessed	by	HRV	is	a	sensitive	method	to	detect	neuropathy,	it	is	less	accurate	in	de-
tecting	sympathetic	dysfunction.130	The	sympathetic	cardiac	innervation	can	nowadays	
be assessed directly and noninvasively with 123I-mIBG	myocardial	scintigraphy	in	many	










as insulin or oral hypoglycaemic agents.1	Inclusion	criteria	consisted	of	confirmed	type	2	
diabetes	mellitus	in	combination	with	complete	absence	of	angina	or	angina-equivalent	








with	 normal	myocardial	 perfusion	 (stress	 and	 rest)	 123I-mIBG	myocardial	 scintigraphy	
was	performed	to	evaluate	the	prevalence	of	sympathetic	CAN	compared	to	the	preva-
lence	of	CAN	assessed	by	HRV.
Adenosine stress SPECT myocardial perfusion imaging
Data	 acquisition	 and	 analysis	 were	 performed	 as	 described	 before.84	 Briefly,	 ECG-
gated	 SPECT	 imaging	 was	 performed	 using	 a	 2-day	 protocol	 (adenosine	 and	 rest)	
with	technetium-99m	sestamibi	(99mTcMIBI).	Twelve-lead	electrocardiography	(ECG)	
was	 recorded	 each	minute	 and	 continuously	monitored	 (leads	 aVF,	 V1	 and	V5)	 for	





















Diabetic autonomic neuropathy 
A	final	test	measured	the	difference	in	systolic	blood	pressure	between	supine	and	up-
right	position.	No	patients	were	 receiving	drugs	 influencing	HRV,	 such	as	neuroleptic	


















tion	or	 in	case	of	extra	systoles	 impairing	 interpretation.	A	decrease	of	systolic	blood	
pressure	equal	to	or	greater	than	30	mmHg	within	2	minutes	after	standing	was	defined	





123i-mIBG myocardial scintigraphy imaging protocol
Data acquisition
Patients	were	instructed	not	to	take	tricyclic	antidepressants	drugs,	sympathetic	agents,	












Data analysis and image interpretation 
Planar images
Early	(15	min	post-injection)	and	late	(4-hour	delayed)	planar	images	were	processed	
to	determine	 the	heart-to-mediastinum	ratio	 (HMR).	The	planar	mIBG	 images	were	














al	 interpretation.	 The	 delayed	myocardial	 SPECT	 images	were	 divided	 into	 17	 seg-
ments and each segment was evaluated in consensus by two expert observers, using 
a	4-point	scoring	system	(0:	>70%	tracer	uptake,	1:	50-70%	tracer	uptake,	2:	30-50%	






Diabetic autonomic neuropathy 
al,	a	TDS	>18	was	considered	abnormal;	when	corrected	for	a	4-point	scoring	system	
(as	used	in	the	current	study),	a	TDS	>13	would	be	considered	abnormal.149 Next, the 
location	of	defects	was	evaluated,	and	categorized	as	inferior,	apical,	lateral,	anterior	



















of diabetes, such as peripheral neuropathy and/or peripheral vascular disease.
 







table 1.  Patient	characteristics	of	88	asymptomatic	patients	with	diabetes	type	2.	Data	










Oral and Insulin 11(13)
Peripheral vascular disease/peripheral neuropathy 9(10)/19(22)

























Diabetic autonomic neuropathy 
Cardiac autonomic neuropathy assessed by 123i-mibg 
Of	the	88	patients,	37	patients	 (42%)	had	a	normal	123I-mIBG	study.	 In	the	remaining	
51	patients	(58%),	the	123I-mIBG	study	was	abnormal.	Of	these	51	patients,	22	patients	











Cardiac autonomic neuropathy assessed by 123i-mibg versus hrV
The	agreement	and	disagreement	between	HRV	and	123I-mIBG	for	the	assessment	of	CAN	
is	shown	in	Figure	1.	Of	the	64	patients	without	CAN	according	to	HRV,	35	patients	(55%)	
had a normal 123I-mIBG	study.	Of	the	24	patients	with	CAN	according	to	HRV,	22	(92%)	












Figure 1.  Agreement	and	disagreement	between	HRV	and	123I-mIBG	scintigraphy	for	the	
assessment of cardiovascular autonomic neuropathy
CAN,	cardiac	autonomic	neuropathy;	HRV,	heart	rate	variability.
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Figure 1. Agreement and disagreement between HRV and 123I-mIBG scintigraphy for the assessment 























CAN: cardiac autonomic neuropathy, HRV; heart rate variability. 

























CAN,	suggesting	 that	123I-mIBG	 imaging	may	be	more	sensitive	 for	 the	assessment	of	
CAN	than	HRV.	














betic	patients	with	 symptoms	and	clinical	 features	 suggestive	of	autonomic	neuropa-
109
Diabetic autonomic neuropathy 
thy who were followed for 33 months.125 The authors concluded that simple autonomic 
function	 tests	 provided	 significant	 prognostic	 information,	with	 abnormal	 tests	 being	
associated	with	a	high	mortality.	These	results	were	confirmed	 in	a	 larger	population	
(n=605)	of	the	Hoorn	study	with	a	follow-up	period	of	9	years.127 Mortality during the 
follow-up	was	17%	 (n=101	patients);	 patients	with	diabetes	 and	 impaired	autonomic	
function	had	a	twofold	mortality	risk.
123I-mIBG	is	an	analog	of	the	false	neurotransmitter	guanethidine.	It	is	taken	up	by	ad-
renergic neurons in a similar fashion to norepinephrine and does not undergo intracellu-
lar	metabolism.	When	labelled	with	123I,	it	can	be	used	to	visualize	adrenergic	receptors	
in	the	myocardium	using	scintigraphic	imaging.155 At present, cardiac 123I-mIBG	imaging	






baseline and at 4 year follow-up.157	Among	the	patients	with	a	poorly	controlled	HbA1c,	
(mean	≥7.6%)	123I-mIBG	uptake	deteriorated	after	4	years.	
Conversely, Schnell and co-workers reported that global and regional 123I-mIBG	uptake	
in	22	asymptomatic	patients	with	type	1	insulin-dependent	diabetes	did	neither	signifi-
cantly regress nor progress on average 123I-mIBG	uptake	over	3	year	follow-up.	These	re-







Previous data have suggested that 123I-mIBG	scintigraphy	may	be	more	sensitive	than	
















In	 the	present	 study,	we	performed	a	 systematic,	head-to-head	comparison	between	
HRV	and	 123I-mIBG	 scintigraphy	 in	 88	 asymptomatic	patients	with	 type	2	diabetes	 to	
evaluate	the	presence	of	CAN.	The	current	study	has	included	much	more	patients	than	
the	previous	studies,	but	although	the	inclusion	criteria	were	different,	our	results	are	
in	 line	with	 previous	 reports	 observing	 a	 significantly	 higher	 proportion	 of	 CAN	with	
123I-mIBG	scintigraphy	compared	to	HRV.137, 161, 162	The	fact	that	more	patients	exhibit	
abnormalities	in	123I-mIBG	imaging	as	compared	to	HRV,	underscores	the	suggestion	that	
abnormalities	 in	cardiac	 sympathetic	 innervation	occur	prior	 to	ECG-based	 (HRV)	car-
diac	autonomic	dysfunction.137	An	alternative	explanation	is	that	123I-mIBG	scintigraphy	
mainly	reflects	sympathetic	innervation,	whereas	HRV	may	be	more	related	to	parasym-
pathetic	function.163 It remains to be determined which of these two parameters may be 






tion	abnormalities.137, 161, 162, 164	For	example,	Langer	et	al	evaluated	65	diabetic	patients	
and	noted	significantly	impaired	123I-mIBG	uptake	in	the	inferior	wall	and	apex.160 Ad-
ditional	studies	have	shown	that	abnormalities	in	CAN	tend	to	occur	first	in	the	inferior	
regions of the myocardium and then progressively spread to adjacent segments.165, 166 
It	may	well	are	that	these	regions	of	reduced	innervation	may	be	more	prone	to	cardiac	
arrhythmias, but this remains to be determined. 





Diabetic autonomic neuropathy 
Clinical implications




cemic control is of great importance in the development and progression of CAN.157, 165 
At	 the	same	time,	poor	glycemic	control	 is	associated	with	poor	outcome.168 Accord-
ingly,	early	detection	of	CAN	is	of	utmost	importance.	As	observed	in	the	current	study,	
123I-mIBG	scintigraphy	appears	more	sensitive	than	HRV	to	detect	CAN	in	asymptomatic	
diabetic	 patients,	without	myocardial	 perfusion	 abnormalities;	 identification	of	 these	
patients	may	permit	risk	factor	modification,	and	intensive	medical	treatment,	aiming	
at	better	glycemic	control,	which	in	turn	may	favourably	affect	outcome.169-172 Indeed, 
several	 studies	have	 shown	 that	 improvement	of	 CAN	 (as	 evidenced	by	HRV)	 can	be	
achieved by weight loss with regular exercise.173, 174	Furthermore,	progression	of	CAN	






compared	 to	HRV.	These	findings	 suggest	 that	 123I-mIBG	myocardial	 scintigraphy	may	










Summary, conclusions and future perspectives 
summary





















with	DM	 type	 2	 by	 single	 photon	 emission	 computed	 tomography	 (SPECT)	MPI,	 CAC	
scoring,	and	multislice	computed	tomography	(MSCT)	coronary	angiography.	We	con-
cluded	that	different	imaging	modalities	visualized	different	aspects	of	silent	coronary	
atherosclerosis.	 Anatomical	 evidence	 of	 coronary	 atherosclerosis	 (as	 determined	 by	
CAC	and	MSCT)	occurred	more	frequently	than	functional	evidence	of	ischemia	(stress	
SPECT).	However,	 clinically	 significant	manifestations	of	 CAD	were	observed	 in	 about	
one-quarter	 to	one-fifth	of	patients	by	each	 imaging	modality,	either	separately	or	 in	
combination.	 The	 purpose	 of	 the	 study	 in	 chapter 4 was to evaluate the prevalence 
of	CAD	as	well	as	plaque	morphology	in	asymptomatic	patients	with	DM	type	2	using	











as independent predictors of an abnormal stress MPI study. In chapter 6, we described a 
case	report	of	a	patient,	who	suffered	a	silent	myocardial	infarction,	despite	early	identi-
fication	of	coronary	atherosclerosis,	followed	by	risk	factor	modification	and	aggressive	
medical therapy. The aim of the study described in chapter 7 was to evaluate whether 
subclinical	 left	ventricular	 systolic	dysfunction	was	 independently	 related	 to	 coronary	
atherosclerosis	and	if	it	provided	incremental	information	over	baseline	characteristics	
to	identify	patients	with	coronary	atherosclerosis.	Compared	to	patients	without	athero-
sclerosis,	 diabetic	 patients	 with	 coronary	 atherosclerosis	 showed	 an	 impaired	 global	
left	 ventricular	 strain.	 The	 presence	of	 subclinical	 left	 ventricular	 systolic	 dysfunction	
provided	significant	 incremental	value	 for	 the	 identification	of	patients	with	coronary	





Conclusions and future perspectives
In	this	thesis,	we	evaluated	several	different	cardiac	imaging	techniques	for	risk	stratify-
ing	asymptomatic	patients	with	DM	type	2.	We	concluded	that	different	 imaging	mo-







subclinical	 left	ventricular	dysfunction	 reflected	by	an	 impaired	global	 left	ventricular	
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Diabetes	 mellitus	 (suikerziekte)	 is	 een	 stofwisselingsziekte,	 die	 gekenmerkt	 wordt	
door te hoge waardes van het suikergehalte in het bloed. Het is een veel voorkomend 
ziektebeeld	 en	 de	 prevalentie	 neemt	 nog	 steeds	 toe.	Het	merendeel	 (90%)	 van	 de	
patiënten	met	diabetes	mellitus	heeft	diabetes	mellitus	type	2,	ook	wel	ouderdoms-
suiker	 genoemd.	Hart-	 en	 vaatziekten	 zijn	 de	belangrijkste	 gevolgen	 van	dit	 ziekte-




langrijk, omdat er voor hen een verhoogd risico bestaat op het krijgen van hart- en 
vaatziekten.	Diverse	beeldvormingstechnieken	van	het	hart,	kunnen	gebruikt	worden	
voor	deze	 risicostratificatie.	 In	dit	 proefschrift	wordt	de	 rol	 bestudeerd	 van	diverse	
beeldvormingstechnieken,	die	gebruikt	kunnen	worden	voor	risicostratificatie	in	een	
groep	van	asymptomatische	patiënten	met	diabetes	mellitus	type	2.	 In	hoofdstuk 1 
van	 dit	 proefschrift	 wordt	 een	 overzicht	 gegeven	 van	 de	 prevalentie	 van	 diabetes	
mellitus	 type	2,	de	gevolgen	hiervan	en	achtergrondinformatie	over	de	verschillen-
de	beeldvormingstechnieken	die	gebruikt	worden	voor	risicostratificatie	 in	deze	pa-
tiëntengroep.	hoofdstuk 2	beschrijft	de,	 in	de	 literatuur	gevonden,	prevalentie	van	
zuurstoftekort	 (ischemie)	 van	 de	 hartspier	 (myocard)	 tijdens	 inspanning,	 gemeten	
met	behulp	van	myocardperfusie	 scintigrafie.	Met	deze	 techniek	wordt	met	behulp	
van	radioactief	materiaal,	de	zuurstofopname	van	de	hartspier	tijdens	rust	en	inspan-
ning	in	beeld	gebracht.	Dit	is	een	indirecte maat voor de ernst van het coronairlijden. 
Coronairlijden kan direct	 in	beeld	gebracht	worden	met	de	multislice	 computer	 to-
mografie	 (MSCT)	 scan.	Hierbij	wordt	o.a.	gebruik	gemaakt	van	de	calciumscore.	De	
calciumscore is een maat is voor verkalking van de kransslagaders. Uit bestudering van 




mellitus type 2 voorgesteld. hoofdstuk 3	beschrijft	een	groep	patiënten,	waarin	met	
behulp	van	myocardperfusie	scintigrafie,	de	calciumscore	en	niet-invasieve	coronair	
angiografie	verschillende	aspecten	van	coronairlijden	in	kaart	werden	gebracht.	Ana-













rijk om te noemen is, dat een lage calciumscore, een vernauwing van de kransslagader 
niet	altijd	uitsloot.	








aanpak	 van	 de	 risicofactoren	 en	 het	 instellen	 van	medicatie,	 een	hartinfarct	wordt	









van 123I- gelabeld mIBG.	Ondanks	het	feit	dat	autonome	dysfunctie	van	het	hart	vaak	
wordt gemeten, leek 123I-mIBG	scintigrafie	een	gevoeligere	methode	te	zijn,	voor	het	
vastleggen	van	autonome	dysfunctie	van	het	hart	bij	asymptomatische	patiënten	met	







diabetes	mellitus	 type	2	 te	 komen.	Uit	het	onderzoek	bleek	onder	meer,	dat	 in	deze	
patiëntengroep	met	de	verschillende	beeldvormingstechnieken,	verschillende	aspecten	
van	asymptomatisch	coronairlijden	 in	kaart	konden	worden	gebracht.	Anatomisch	be-
wijs	 voor	 coronairlijden	 (calciumscore	en	niet-invasieve	 angiografie)	bleek	 vaker	 voor	







strain	 van	 de	 linker	 kamerfunctie,	 konden	 binnen	 deze	 patiëntengroep,	 de	 patiënten	
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